| Inde | Turquie | Espagne | |
| Thérapie par cellules souches pour la SLA (sclérose latérale amyotrophique) | de $8,500 | de $30,000 | de $40,000 |
| Thérapie par cellules souches | de $3,000 | de $7,300 | de $8,500 |
| Plasmaphérèse | de $4,200 | de $1,200 | de $1,800 |
| Thérapie par cellules souches pluripotentes induites | de $18,500 | - | - |
Bookimed ne rajoute pas de frais pour les traitements de La sclérose latérale amyotrophique. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de La sclérose latérale amyotrophique et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de La sclérose latérale amyotrophique.
Stem-cell therapy for ALS in India is legal only within approved clinical trial frameworks and is not recognized as a standard medical treatment. Indian regulatory bodies like the National Medical Commission (NMC) classify commercial marketing of these experimental procedures as professional misconduct due to unproven clinical effectiveness.
Bookimed Expert Insight: While India hosts highly accredited facilities like JCI-certified Apollo Hospital Indraprastha and Global Hospital Chennai, patients must distinguish between their world-recognized transplantation services and experimental ALS clinics. Data shows that while top-tier Indian centers excel in standard care, some smaller facilities rebrand stem-cell procedures as regenerative therapy to bypass strict government advertising bans. Always verify if a center holds specific Drug Controller General of India (DCGI) approval for clinical trials before proceeding.
Patient Consensus: Patients note that clinics often promise high success rates, but reality usually involves only a short-term energy boost followed by rapid decline. Many warn that these expensive treatments frequently drain finances without providing lasting physical benefits or halting disease progression.
Ayurvedic treatments manage ALS symptoms by balancing the nervous system and nourishing muscles. These therapies aim to improve physical function and quality of life. Common protocols include Panchakarma detoxification and herbal oils. They complement standard care but do not cure the underlying condition.
Bookimed Expert Insight: Patients seeking ALS support often prioritize multi-specialty hubs like Apollo Hospital Indraprastha because they offer advanced diagnostics. While Ayurveda focuses on comfort, accessing centers with NABL-accredited laboratories ensures accurate monitoring of respiratory and motor functions during therapy. This dual approach provides a safer framework than visiting isolated wellness clinics.
Patient Consensus: Patients note that Ayurvedic treatments are helpful for easing muscle twitches and improving digestion. However, they warn that these therapies should never replace conventional medications like Riluzole or professional respiratory care.
Indian hospitals provide multidisciplinary ALS care centered on slowing progression and managing symptoms. Standard treatments include FDA-approved medications like Riluzole and Edaravone. Accredited centers such as Apollo and Fortis integrate neurology, pulmonology, and physiotherapy. They also offer respiratory support through Non-Invasive Ventilation and BiPAP machines.
Bookimed Expert Insight: Patients should prioritize hospitals with a Full Time Specialist System like Kokilaben Dhirubhai Ambani. These institutions ensure neurologists and pulmonologists are always available for urgent respiratory adjustments. This integrated access is more effective than visiting separate clinics for each symptom.
Patient Consensus: Patients note that standard care is more reliable at major metro hospitals. They warn others to rely on supportive therapies rather than unproven stem cell treatments.
Hospitals specializing in ALS rehabilitation and respiratory support include JCI-accredited centers in India and Thailand. These facilities provide multidisciplinary teams of neurologists, pulmonologists, and physical therapists. Leading institutions offer advanced non-invasive ventilation (NIV) and personalized rehabilitation programs for international patients.
Bookimed Expert Insight: While US centers are renowned, Indian Super Specialty hospitals provide comparable respiratory weaning at a different scale. Global Hospital Chennai serves 80,000 patients and excels in lung-related technologies. For ALS patients, this volume translates to high proficiency in complex ventilatory support protocols. Look for hospitals with NABH and JCI accreditations to ensure international safety standards.
Patient Consensus: Patients note that private hospitals like Max Healthcare offer faster access to speech and swallow therapy. Families emphasize the importance of securing portable ventilators and coordinating with international desks for visa assistance early.
Stem cell procedures for ALS in India carry documented risks including injection site reactions, fever, and neurological complications like meningitis-like symptoms. The Indian Council of Medical Research (ICMR) strictly limits these treatments to clinical trials due to limited scientific evidence regarding safety and efficacy.
Bookimed Expert Insight: While India hosts highly accredited facilities like JCI-certified Apollo Hospital Indraprastha and NABH-accredited Global Hospital Chennai, these institutions primarily focus on established transplants. Patients should note that high-ranking hospitals prioritize regulatory transparency. If a clinic offers stem cell therapy for ALS as a routine service rather than a trial, it likely lacks the oversight found at major centers like Fortis Gurgaon.
Patient Consensus: Patients report experiencing temporary numbness and localized pain after spinal injections. Many emphasize the need to demand peer-reviewed data rather than relying on clinic success claims.
Medical tourists should plan a 7 to 21 day stay in India for a comprehensive amyotrophic lateral sclerosis evaluation. This timeframe allows for specialized neurological assessments and diagnostic imaging. It also includes initial treatment phases such as antioxidant infusions or innovative stem cell approaches.
Bookimed Expert Insight: Patient data shows major centers like Apollo Hospital Indraprastha and Global Hospital Chennai manage massive volumes. Global Hospital serves 2 million patients annually across 44 departments. Choosing these high-capacity facilities often secures faster access to diagnostic equipment compared to smaller specialized clinics.
Patient Consensus: Patients value the speed of Indian diagnostics, noting same-day MRIs are often possible. Many emphasize the need for a 4-week buffer to handle potential delays or extended therapy sessions.